FDA Drug Application (021971) for LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE by CIPLA LIMITED

Back to FDA Applications sponsored by CIPLA LIMITED

Application Number021971
Product Number001
FormTABLET; ORAL
Dosage150MG; 300MG; 200MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMIVUDINE; ZIDOVUDINE; NEVIRAPINE
Active IngredientLAMIVUDINE; ZIDOVUDINE; NEVIRAPINE



Back to FDA Applications sponsored by CIPLA LIMITED

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.